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BACKGROUND: New models continue to be required to improve our understanding of colorectal cancer progression. To this aim, we
characterised in this study a three-dimensional multicellular tumour model that we named colospheres, directly obtained from
mechanically dissociated colonic primary tumours and correlated with metastatic potential.
METHODS: Colorectal primary tumours (n¼203) and 120 paired non-tumoral colon mucosa were mechanically disaggregated into
small fragments for short-term cultures. Features of tumours producing colospheres were analysed. Further characterisation was
performed using colospheres, generated from a human colon cancer xenograft, and spheroids, formed on agarose by the paired
cancer cell lines.
RESULTS: Colospheres, exclusively formed by viable cancer cells, were obtained in only 1 day from 98 tumours (47%). Inversely, non-
tumoral colonic mucosa never generated colospheres. Colosphere-forming capacity was statistically significantly associated with
tumour aggressiveness, according to AJCC stage analysis. Despite a close morphology, colospheres displayed higher invasivity than did
spheroids. Spheroids and colospheres migrated into Matrigel but matrix metalloproteinase (MMP)-2 and MMP-9 activity was
detected only in colospheres. Mouse subrenal capsule assay revealed the unique tumorigenic and metastatic phenotype of
colospheres. Moreover, colospheres and parental xenograft reproduced similar CD44 and CD133 expressions in which CD44
þ cells
represented a minority subset of the CD133
þ population.
CONCLUSION: The present colospheres provide an ex vivo three-dimensional model, potentially useful for studying metastatic process.
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Colorectal cancer (CRC) is a major cause of morbidity and
mortality worldwide, and CRC patient death is generally attribu-
table to metastasis development and resistance to chemotherapy.
Human CRC is one of the most extensively investigated tumour
types, and genetic pathways involved in these malignancies have
been identified (Fearon and Vogelstein, 1990). However, complex
factors involved in CRC metastasis remain largely undefined and
there is a need for effective drugs for treatment. In this context,
successful future treatments must rely on a comprehensive
analysis of events underlying the metastatic process, together with
the development of new model systems that could be easily
manipulated so as to evaluate the efficacy of novel therapeutics.
The importance of studying cancer cells in 3D has been recently
emphasised because of their higher relevance for an in vivo
situation (Jacks and Weinberg, 2002; O’Brien et al, 2002; Yamada
and Clark, 2002; Debnath and Brugge, 2005; Smalley et al, 2006).
For this purpose, some permanent cancer cell lines, including
colon cancer cell lines, are able to form spheroids when cultured in
non-adherent conditions (for review, Friedrich et al, 2007). These
spheroids are recognised to mimic microtumours more closely
than cancer cell line monolayers and have been used mainly in
chemo- and radioresistance studies. Another 3D cell model aims at
promoting the expansion of cancer stem cells from solid tumour
tissue after enzymatic dissociation in single-cell suspensions. This
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sapproach, first described for the expansion of normal or cancer
brain cell in neurospheres (Svendsen et al, 1998), required a
specific culture protocol and, in the case of CRC, led to the colon
cancer sphere model (Ricci-Vitiani et al, 2007; Todaro et al, 2007;
Vermeulen et al, 2008).
In this study, carried out on a series of 203 CRC primary
tumours, we describe a model of 3D cellular structures sponta-
neously generated after an ex vivo mechanical dissociation of CRC
tissue. We refer to these 3D structures as colospheres. To further
characterise these colospheres, we used a human colon cancer
xenograft, XenoCT320, and the derived paired colon cancer cell
lines, CT320X6 and CT320 (Dangles-Marie et al, 2007). Colo-
spheres generated from xenograft tissue and spheroids formed on
agarose from colon cancer cell lines were then studied in parallel.
MATERIALS AND METHODS
Patients and tissue specimens
The CRC primary tumours were collected from the Institut
Mutualiste Montsouris (Paris, France) and the Institut Gustave
Roussy (Villejuif, France) from 203 patients observed between May
2003 and May 2006, in accordance with protocols approved by the
local ethical committees and with the Helsinki Declaration of 1975,
as revised in 1983.
Tumour material not required for histopathological diagnosis
was placed in a ‘culture medium’ (DMEM supplemented with 10%
decomplemented FCS, 10mmoll
 1 HEPES, 4.5gl
 1 glucose,
1mmoll
 1 pyruvate sodium, 200Uml
 1 penicillin and 200mgml
 1
streptomycin) and submitted to ex vivo mechanical mincing.
Colosphere-forming assay
Tissue fragments of approximately 0.5 0.5 0.5cm were sub-
mitted to mechanical dissociation in Petri dishes: after a medium
washing step, tissue sample was first finely cut with a scalpel blade
and then crushed with a striated plunger from a disposable
syringe. The resulting pieces were transferred to a 25-cm
2 culture
flask containing the ‘culture medium’ and incubated at 371C, in
8% CO2.
Dissociated tumour cultures were scored by a double-blind light
microscopical examination at  10 magnification by two different
observers. A minimum of five fields per flask were viewed.
Colosphere formation was scored on day 1 after culture as follows:
( ), no colosphere observed; (þ), p2 colospheres per field;
(þþ), 42 colospheres per field.
Xenograft and spheroid culture
XenoCT320 xenograft, CT320 and CT320X6 cell lines have been
previously described (Dangles-Marie et al, 2007). For xenograft
passage, tumour fragments were subcutaneously grafted in the
interscapular region into 5-week-old athymic nude female mice
(Harlan, Winkelmann, Germany) bred and maintained in specified
pathogen-free conditions (protocol approval no P2.VDM.026.07,
local ethical committee on animal experiments, CREEA Rene ´
Descartes, Paris, France).
For spheroid culture, tumour cells grown as a monolayer were
resuspended with trypsin, and 5 10
3 cells were seeded in
microwells coated with 1% agarose so as to obtain, after 3 days,
a single spheroid per well.
2D multipositioning light videomicroscopy
Colosphere and spheroid development was monitored by time-
lapse video microscopy for 65h at a 4min interval. Dynamic
sequences were obtained on a DM IRBE stand equipped with a
motorised stage (Leica, Mannheim, Germany) using a 371C8 %
CO2-humidified stage-top incubator (Life Imaging Services, Basel,
Switzerland).
Histological characterisation
Colospheres and spheroids were embedded using the Cytoblock
method (Briffod et al, 2000) and the Shandon kit (Thermo electron
corporation, Saint Herblay, France). Immunostaining was per-
formed on the resulting paraffin sections using an automated
immunostainer (Ventana, Strasbourg, France) with mAb to Ki67
antigen (MIB1 clone; Dako, Trappes, France) and to E-cadherin
(4A2C7 clone; Zymed, Montrouge, France). At least eight
independent samples were collected for the specific analysis of
colospheres and spheroids.
TBP gene expression
Specific mouse TBP gene expression and the expression of both the
mouse and the human TBP genes were studied by real-time
quantitative RT–PCR (Le ´vy et al, 2004) to determine the quantity
of mouse cells in human xenografts and colospheres. With the
assistance of the computer program Oligo 5.0 (National Bios-
ciences, Plymouth, MN, USA), the murine Tbp primer pair was
selected to be mouse specific when compared with the sequence of
the human TBP gene, whereas the total TBP primer pair was
selected to amplify both the mouse and the human TBP genes.
BLASTN searches against dbEST and nr (the non-redundant set of
the GenBank, EMBL and DDBJ database sequences) were
conducted to confirm the total gene specificity of the nucleotide
sequences chosen for the primers and for the absence of DNA
polymorphisms. The nucleotide sequences of the primers used
were the following: Mm-TBP-U (50-CCCTTGTACCCTTCACCAA
TGAC-30) and Mm-TBP-L (50-TCACGGTAGATACAATATTTTG
AAGCTG-30) and Total-TBP-U (50-TGCACAGGAGCCAAGAGTG
AA-30) and Total-TBP-L (50-CACATCACAGCTCCCCACCA-30).
The thermal cycling conditions comprised an initial denaturation
step at 951C for 10min, and 50 cycles at 951C for 15s and 651C for
1min.
Results, expressed as N-fold differences in the specific murine
Tbp gene expression (using Mm-TBP primers), relative to the sum
of the mouse and the human TBP gene expression (using Total-
TBP primers), termed NMm-TBP, are determined by the formula:
NMm-TBP¼2
DCtsample. The DCt value of the sample is determined
by subtracting the Ct value of the murine TBP gene from the
Ct value of the total (mouseþhuman) TBP gene. The NMm-TBP
values of the samples are subsequently normalised such that the
median of the NMm-TBP values of four mouse tissues was 100. As
TBP is a ubiquitously expressed housekeeping gene, which encodes
the TATA box-binding protein, a component of the DNA-binding
protein complex TFIID, and shows a similar expression in our
human and mouse tissues (Ct¼27 for 5ng cDNA), the final result
(normalised NMm-TBP value) determines the proportion of mouse
cell contamination for a given sample.
Electron microscopy
After harvesting, colospheres and spheroids were analysed using
standard techniques for transmission electron microscopy (Riba-
deau Dumas et al, 2004). Ultrathin sections were examined at
80kV using a JEOL JEM-1005 electron microscope (JEOL S.A.,
Croissy-sur-Seine, France). For scanning electron microscopy
(SEM), cells were critical-point dried in hexamethyldisilizane
(Sigma-Aldrich, Saint-Quentin, France). Samples were mounted on
specimen stubs, sputter coated with gold using JEOL JCF100 and
examined at 16kV using JEOL ISM-35CF. At least six samples for
CT320X6 and CT320 spheroids and for XenoCT320 colospheres
were submitted to electron microscopy examination.
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The tumorigenicity of XenoCT320 colospheres, CT320X6 spher-
oids and CT320X6 single cells was compared in a subrenal capsule
assay in nude mice. Three days after xenograft tissue dissociation,
colospheres of 100–150mm diameter were manually collected
under the microscope and an aliquot was trypsinised to estimate
the number of viable cells in the colospheres. The concentration
was adjusted to have a number of colospheres equivalent to 4 10
4
cells per 10ml for intrarenal injection. Similarly, eight spheroids
formed by seeding 5 10
3 cells per microwell were injected in
10ml. As spheroids from this cell line grow slowly, spheroids
collected 3 days after initiation contained about 5000 cells per
spheroid for a diameter of about 150mm. An oblique incision was
made on the skin parallel to the long axis of the right kidney in
anaesthetised mice (xylazin/ketamin protocol). Injections of cells
equivalent to 4 10
4 cells were administered with a 27G needle in
the subcapsular space in the right kidney. The internal diameter of
the 27G needles is 200mm at the minimum, which would avoid any
damage on spheroids and colospheres. After cell injection, the
kidney was then returned to the peritoneal space and the skin was
closed with surgical staples. The recipient mice were necropsied at
14 weeks after injection and kidneys, spleen, lung and liver were
removed for histological examination.
Tumorigenicity of the CT320X6 cell line was carried out in
parallel in nude mice by the subcutaneous transplantation of
2 10
6 viable cells in 0.2ml of PBS. The mice were observed for 2
months for the appearance of tumour development.
Matrigel assay
Colospheres and spheroids were added to Matrigel solution
(3mgml
 1) (BD Biosciences, Le Pont de Claix, France) in 24-well
plates before polymerisation of the lattice. Culture medium was
added to the Matrigel layer.
Gelatin zymography
Gelatin zymography assays were performed with a Bio-Rad
laboratories kit (Marnes La Coquette, France), according to the
manufacturer’s instructions. Colospheres, spheroids and xenograft
tissue were lysed with zymogram sample buffer and the amount of
protein was estimated using the Bradford method (Biorad Dc
Protein Assay; Bio-Rad Laboratories). Twenty micrograms of
protein from each sample was separated on polyacrylamide gels
containing 10% gelatin. After electrophoresis, the gels were washed
in renaturation buffer for 30min, and incubated overnight at 371C
in the development buffer. Gels were stained with a Coomassie
blue R250 0.5% solution and destained with 3  destaining
solution.
Flow cytometric analysis
Disaggregated colospheres, spheroids and xenografts were as-
sessed using an Epics XL cytometre (Coulter, Villepinte, France)
with the following antibodies: anti-human CD133/2 (clone 293C3)
phycoerythrin, anti-human EpCAM (clone HEA-125) fluorescein
isothiocyanate (Miltenyi-Biotec SAS, Paris, France) and anti-
human CD44-FITC (clone G44-26; BD Biosciences), at appropriate
dilutions. As for xenograft tissue, human colon cancer cells were
magnetically labelled and separated from mouse stroma cells using
human EpCAM microbeads (Miltenyi-Biotec SAS) according to the
manufacturer’s instructions, before assessment by flow cytometry.
Confocal microscopy
About 30 colospheres in suspension were fixed for 3h at 41Ci n
PBS containing 4% PFA, followed by washes in PBS. Colospheres
were then permeabilised in 1% Triton X-100 in PBS for 1h and
washed with PBS. After a 1h incubation in PBS/NH4Cl
(50mmoll
 1), followed by washes in PBS, colospheres were
saturated overnight with 3% BSA in PBSt (0.1% Triton X-100 in
PBS) at 41C and washed in PBSt. Colospheres were incubated for
24h at 41C with anti-human EpCAM-FITC (clone HEA-125) in
PBSt (dilution 1:50) and rinsed with PBSt. The DNA marker,
TOPRO-3 (Invitrogen-Molecular Probes, Cergy Pontoise, France),
was then applied for 20min at room temperature. Colospheres
were mounted in glycerol/PBS (90/10: v/v). Images were recorded
on a Leica TCS SP2 confocal microscope.
RESULTS
Observation of colospheres within ex vivo dissociated
colon primary tumours
Dissociation of 203 fresh colon primary tumour tissues directly
harvested from human patients undergoing surgery led to the
formation of spherical organoid structures, which we named
colospheres (Figure 1A), in 98 out of the 203 specimens (47%) in
just 1 day. Colospheres displayed a diameter comprised between 20
and 200mm and were easily identifiable because of their smooth
refringent outline. To determine whether the property to form
such colospheres from patient tumours was a feature restricted to
cancer tissue, the same mechanical dissociation protocol was
carried out in parallel with non-tumoral colon tissue counterparts
from 120 of these 203 tumour tissues. It is noteworthy that no
colospheres were ever observed after dissociation of non-
neoplastic colonic mucosa, showing that these spherical structures
are only generated by cancer tissue. Among these 98 specimens, 28
tumours led to the generation of a large number of colospheres.
Colospheres formed by highly compacted cells were resistant to
mechanical disruption. On the basis of haemalun–eosin–safran
(HES) staining, only carcinoma cells were observed in colospheres,
whereas no stromal cells were recognised (Figure 1B), indicating
that colospheres were structured aggregates of cancer cells and not
merely globular fragments of tumour tissue. EpCAM staining
performed with cytometry analyses or confocal microscopy
confirmed the epithelial origin of colosphere-forming cells (Figure
1D–F). Anti-Ki67 immunostaining showed that colospheres
contained viable proliferating cells (Figure 1C).
Tumour collection was divided into two groups: non-dissemi-
nated tumours (AJCC stage I and II) and disseminated tumours
(AJCC stage III and IV), as AJCC stage I and II tumours differ from
stage III and IV tumours by the fact that the latter group displays
metastases in lymph nodes and/or in distant organs. Thus, the
capacity of primary tumours to form colospheres was found to be
significantly correlated with tumour aggressiveness. Indeed,
statistical analysis showed that the stage III and IV tumour groups
gave rise more frequently to colospheres than did the stage I and II
tumour groups (Po0.01; Figure 2).
Colosphere morphology studies
For a further characterisation of colospheres, the production of a
large quantity of reproducible biological material was required. For
this purpose, we used human colon cancer xenograft XenoCT320,
previously established from a human primary tumour (Dangles-
Marie et al, 2007). The tumour fragment F320 leading to the
XenoCT320 establishment came from a patient who presented
synchronous liver metastasis. In nude mice, axiliar lymph nodes
were tumour positive when collected after the removal of the
tumour xenograft and recurrence at the original engraftment site
was observed (data not shown). Similar to the parent colon cancer
specimen, which was included in the former clinical study,
XenoCT320 tissue generated colospheres after ex vivo mechanical
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sdissociation. Furthermore, the morphological features of colo-
spheres are close to those of spheroids generated in vitro using
permanent carcinoma cell lines. This prompted us to compare
XenoCT320 colospheres with spheroids derived from the CT320X6
cell line, previously established from the XenoCT320 tumour, and
with spheroids derived from the CT320 cell line, established from
the same original patient tumour fragment as the xenograft
(Figure 3).
To analyse the dynamic nature of cellular events leading to
colosphere formation in only 1 day, dissociated XenoCT320 tissue
was filmed as a 2D outline every 4min for 65h (Figure 4 and
Supplementary Video 1). This real-time monitoring clearly showed
that large colospheres (450mm) were generated by remodelling of
tissue fragments, whereas smaller colospheres were spontaneously
formed by the aggregation of single cells. Interestingly, the rapid
generation of colospheres was not because of the presence of FCS,
as similar experiments performed in FCS-free medium led to the
same observation (data not shown).
Morphology studies were further investigated by SEM experi-
ments that confirmed the high degree of compaction of these well-
rounded structures (Figure 3A). Moreover, the outer surface of
both colospheres and spheroids appeared quite smooth, in
contrast to the thick filament network of extracellular matrix
components entirely covering the surface of spheroids described
for the human colon carcinoma HT29 cell line (Santini and
Rainaldi, 1999). Using histological examination (Figure 3B), only
cancer cells were observed in XenoCT320 colospheres. This
observation was confirmed by cytometry analysis performed with
anti-epithelial-specific human antigen EpCAM, which showed a
consistent staining of all colosphere-forming cells. Real-time
quantitative RT–PCR using primers specific for mouse Tbp
confirmed the absence of mouse cells in human XenoCT320
colospheres, whereas this approach always showed the presence of
mouse (stromal) cells in human XenoCT320 tumour tissue
(rateo10%). Although XenoCT320 colospheres mimicked adeno-
carcinoma, CT320X6 and CT320 spheroids resembled only
carcinoma morphology. In addition, Ki-67 staining showed that
colospheres were made up of viable proliferating cells. Viability
assays confirmed that colospheres remained alive for up to a
minimum of 3 weeks when transferred on agarose to avoid
adherence to substrate (Supplementary Figure S1). However, the
latter cells proliferated less strongly than did cells forming
spheroids (Figure 3C).
Migration and invasion properties of colospheres
As the above results from 203 patient primary tumours showed a
correlation between aggressiveness of the tumour and its ability to
form numerous colospheres, we next investigated the migratory
and invasive properties of colospheres. Carcinoma invasiveness is
often characterised by an epithelial-to-mesenchymal transition
(EMT)-like dedifferentiation of tumour cells, a process by which
epithelial cell layers lose polarity and cell–cell contact and
undergo remodelling of the cytoskeleton, leading to a migratory
phenotype (Bates and Mercurio, 2005). The nature of the cellular
junction and the expression of E-cadherin, a caretaker of EMT,
were thus investigated in colospheres and spheroids. Using
AJCC stage I and II tumours (n=98)
AJCC stage III and IV tumours (n=105) n=47
n=58
0% 100% 80% 60% 40% 20%
22 36
6 34
Figure 2 Colosphere formation is associated with tumour aggressive-
ness. Figure showing the number of primary tumours giving rise to many
colospheres (‘þþ’, ’), a few colospheres (‘þ’, ) or no colosphere
(‘ ’, &) in non-disseminated tumours (AJCC stages I and II) and in
disseminated tumours (AJCC stages III and IV). Colosphere formation was
scored as described in Materials and Methods.
Figure 1 Colospheres derived from colon carcinoma patient tissue. (A) Photomicrograph of a representative colosphere generated on tissue culture
plastic; (B) HES staining; (C) anti-Ki67 staining. Magnification:  40. (D–F) Confocal immunofluorescence of colospheres. (D) TOPRO-3 staining;
(E) EpCAM staining; (F) overlay of (D) and (E). Scale bar: 50mm.
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selectron microscopy, glandular structures with mucus, microvilli
and desmosomes were found both in spheroids and colospheres,
indicating a gut epithelial origin (Figure 5A). Nevertheless, zonula
occludens, signs of tight junctions, were observed in spheroids but
not in colospheres. E-cadherin immunostaining showed that
membrane expression was more disturbed in colospheres than in
spheroids (Figure 5B).
For functional analysis, colospheres and spheroids were
embedded in Matrigel in the absence of a chemoattractant.
Spherical multicellular cell aggregates were then imaged during 3
days in culture. Although colospheres and spheroids were shown
above to be compacted structures using SEM, it was observed that
single cells succeeded in detaching from colospheres in the
Matrigel assay (Figure 5C and Supplementary Figure S2A). As
for spheroids, even if larger size of spheroid clusters was shown, no
isolated cell could be observed (Figure 5C and Supplementary
Figure S2B).
Movement into Matrigel requires extracellular matrix degrada-
tion. Two major matrix metalloproteinases (MMPs) in colon
cancer, MMP-2 and MMP-9, were then studied using gelatin
zymography. Although protein extracts of spheroids displayed no
gelatinase activity, colospheres and xenograft exhibited both
MMP-2 and MMP-9 activity (Figure 5D).
We then tested the biological features and metastatic character-
istics of colospheres through the subrenal capsule implantation of
a low and equivalent number of human colon cancer cells (4 10
4)
XenoCT320 colospheres CT320X6 spheroids
Culture
on
agarose
Culture
on
agarose
In vitro
mechanical
dissociation
Moderately differentiated colon
adenocarcinoma F320
XenoCT320 xenograft
established from F320
CT320X6 cell line
established from XenoCT320
CT320 cell line
established from F320
CT320 spheroids
Figure 3 Experimental protocol leading to the production of XenoCT320 colospheres and paired spheroids of CT320X6 and CT320 cell lines.
Colospheres (left panel), CT320X6 spheroids (middle panel) and CT320 spheroids (right panel) underwent SEM. (A) Bar¼100mm; HES staining (B); anti-
Ki67 immunostaining (C); magnification:  20.
Colospheres formed ex vivo by colon carcinoma
L-B Weiswald et al
477
British Journal of Cancer (2009) 101(3), 473–482 & 2009 Cancer Research UK
M
o
l
e
c
u
l
a
r
D
i
a
g
n
o
s
t
i
c
sinjected as XenoCT320 colospheres, as CT320X6 spheroids or as a
cell suspension from the CT320X6 cell line (Figure 6A). The
subcutaneous injection of a large number of CT320X6 cells
(2 10
6 cells) as single cells or spheroids proved that this cell
line was tumorigenic in nude mice. Tumour formation at the
injection site occurred in 6 out of 15 mice injected with
XenoCT320 colospheres. Conversely, CT320X6 spheroids formed
no tumour (0 out of 15) and in the CT320X6 single-cell suspension,
only one local tumour was formed in 1 out of 13 cases. In addition,
a gross and histological examination of potential organ distant
sites revealed the unique tumorigenic and metastatic phenotype of
the colospheres: metastases were only observed in the case of
colosphere injection (Figure 6B).
Expression of colon cancer stem cell markers by
colospheres
Floating spherical cell cluster cultures, such as colon cancer
spheres, mammospheres and neurospheres, have been described
as being valuable models for cancer stem cell culture. The round
compact morphology of colospheres resembles that of colon
cancer spheres. This observation and the fact that colospheres are
more efficient than spheroids in the initiation of tumour growth
and metastasis in immunodeficient mice led us to study the
membrane expression of two cancer stem cell markers, CD133 and
CD44, in XenoCT320 colospheres. We then compared this
expression with that of human cancer cells in XenoCT320 tissue
and with that of CT320X6 and CT320 spheroids (Table 1).
Colospheres, spheroids and carcinoma cells in xenograft highly
expressed CD133. Even if the variability of the CD133
þ cell
number was high in colospheres and xenografts according to SEM,
the profile of this cell sub-population was similar in parental
xenograft and derived colospheres. In contrast to CD133, CD44
was expressed to a weaker extent in human cancer cells in
xenograft tissue and colospheres than in spheroids. All CD44
þ
cells were CD133
þ in colospheres and xenografts, whereas a sub-
population of CD44
þ/CD133
  cells was present in spheroids.
Furthermore, the CD133 and CD44 phenotype of colospheres
remained stable even after 21 days of ex vivo culture (Flow
cytometry data: 47.9%±14 CD133
þ cells, 2.1%±1.8 CD44þ cells,
at D21, three independent experiments).
DISCUSSION
This study reports the identification of colospheres, a newly
characterised 3D cancer cell model directly obtained from
dissociated human CRC tissue and associated with tumour
aggressiveness. This model differs first from classical spheroids
in that colospheres are obtained after short-term culture and not
with permanent cell lines and, second, in that colospheres and
spheroids clearly display distinct phenotype features.
The first step of this work was based on a large series of primary
colon tumour specimens collected from 203 patients. After
mechanical disruption, 98 tumours led to colospheres. A striking
point is that the capacity to generate colospheres is not an intrinsic
property of colon mucosa, which is not capable of generating
colospheres. In contrast, only tumour epithelial cells are able to
aggregate in a compact way to lead to spherical well-organised
structures. The observation of such organoid structures has been
reported by a limited number of studies aimed at establishing in
vitro human colon cancer cell lines (McBain et al, 1984; Park et al,
1987; Oh et al, 1999) or in culture from glioma and bladder cancer
biopsy specimens (Bjerkvig et al, 1992), but have never been
studied further. We showed that the capacity to form colospheres
was related to aggressiveness of the tumour, as defined by its AJCC
stage. Indeed, tumours displaying local lymph node metastasis
(stage III) or distant metastasis (stage IV) are more susceptible to
form colospheres than are stage I and II tumours.
As colospheres are exclusively formed by cancer cells, they
represent a 3D ex vivo culture model clearly distinct from the
T=0
T+26 h
T+39 h
T+13 h
T+52 h
T+65 h
Figure 4 Genesis of XenoCT320 colospheres. Pictures, taken as
representative of four independent experiments, at T¼0 after tumour
tissue dissociation, Tþ13, Tþ26, Tþ39, Tþ52 and Tþ65h.
Bar¼100mm.
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s‘tumour fragment spheroids’ model that consists of a variable
mixture of cancer and stromal cells, obtained using the long-term
cultivation of tumour biopsy specimens in an organotypic tissue
manner (Wibe et al, 1984; Fjellbirkeland et al, 1995). The
histological features of colospheres, including high compaction,
numerous mitoses and nucleolar atypia, are close to those of both
microtumours observed upon cytological analysis of carcinoma
ascites and to a lesser extent to those of poorly differentiated
spheroids generated with permanent carcinoma cell lines (Santini
and Rainaldi, 1999).
To further characterise these colospheres, a large quantity of
reproducible biological material was required. To this aim, we used
a model based on a human colon cancer xenograft (XenoCT320),
able to generate colospheres after ex vivo dissociation, and the
derived colon cancer cell lines, CT320 and CT320X6, able to form
compact spheroids on agarose. Similarly, we used another pair of
xenograft and corresponding cell lines established in the
laboratory: the XenoCT329 xenograft established from a human
primary colon tumour sample in nude mice, the CT329 cell line
established directly from the tumour patient and the CT329X12
cell line derived from XenoCT329 (Dangles-Marie et al, 2007).
Colospheres were collected from dissociated XenoCT329 tissue and
compared with CT329 and CT329X12 spheroids (data not shown),
with comparable results with the CT320 model. This study model
provided a unique opportunity to compare colospheres from
dissociated CRC xenograft tissue with a conventional 3D multi-
cellular spheroid model, derived from the same tumour specimen.
It is noteworthy that the remarkable degree of organisation of
colospheres was not dependent on either an exogenous basement
membrane or culture within a 3D matrix, unlike the in vitro
spheroid tumour model. Indeed, all dissociation cultures of CRC
primary tumours leading here to colospheres were carried out in
tissue-culture-treated flasks.
Comparison of morphological structures in colospheres and
spheroids in our study model revealed that, despite their
compaction, colospheres did not display tight junctions. They
also displayed a disturbed expression of E-cadherin, one of the
caretakers of the epithelial phenotype, compared with spheroids.
Although the role of EMT in carcinoma dissemination is
controversial (Christiansen and Rajasekaran, 2006), downregula-
tion of E-cadherin has been linked to invasion and metastasis in
CRC (Bates and Mercurio, 2005). These observations suggest that
colosphere-forming cells maintain EMT potential. The putative
involvement of these cells in cancer spread was underlined by the
colospheres’ ability to migrate into Matrigel. Indeed, one of the
first events that metastatic cells have to complete is the local
invasion of stroma, a process that requires a degradation of
extracellular matrix components by proteolytic enzymes including
MMPs (Fidler, 2002; Pantel and Brakenhoff, 2004). One particular
group of MMPs, the gelatinases A and B, also known as MMP-2
and MMP-9, are of particular interest with respect to the
development and progression of CRC (Garbett et al, 1999; Mook
et al, 2004). Gelatinase analysis showed that ex vivo colospheres
displayed MMP-2 and MMP-9 activity, as did parental xenograft
tissue, whereas paired cell line spheroids were devoid of such
proteases. More importantly, as shown by a subrenal capsule assay,
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Figure 5 In vitro invasion and migration properties of XenoCT320 colospheres and CT320X6 and CT320 spheroids. These results are from one
experiment representative of at least three independent experiments. (A) TEM experiments show acini with microvillosities (left panel), desmosomes
(arrows) and zonula occludens (bracket). (B) Anti-E-cadherin immunostaining. Magnification:  20. (C) XenoCT320 colospheres and CT320X6 spheroids
were embedded in Matrigel. Cultures were photographed at days 0 and 3 after embedding. Single-cell motility could be observed with colospheres (red
arrow). (D) Results from gelatin zymography. Detection of MMP-2 and MMP-9 activity in lysates of XenoCT320 tissue and in derived colospheres but not in
CT320X6 spheroids.
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scolospheres displayed undoubtedly a high tumorigenicity and
metastatic potential, compared with the spheroid model, suggest-
ing that these 3D structures contained more cancer-initiating cells.
It could be hypothesised that the different tumorigenicity is related
to a higher passage number into mice for xenografts giving rise to
colospheres than for xenografts leading to the CT320X6 cell line.
Nevertheless, the presumed selection of more aggressive cells
through in vivo passage is not so clear. We have determined that
the CT320 cell line, established directly from a patient sample
without any passage into mice, and the CT320X6 cell line, derived
from the xenograft XenoCT320, display a similar growth curve in
nude mice (unpublished data). It is also noteworthy that tumours
obtained after injection of colospheres were well-differentiated
adenocarcinomas, whereas tumours derived from a cell-suspen-
sion injection were poorly differentiated carcinomas, illustrating,
as largely observed (personal communication, Heiner Fiebig), that
cancer cell lines established from differentiated human tumours
lead to poorly differentiated tumours, whereas xenografts directly
from tissue tumour specimens maintain their differentiation level.
The differences observed between colospheres and spheroids have
to be put in line with the different growth conditions (ex vivo vs
in vitro), which in turn involve different microenvironments. The
impact of the microenvironment – such as cell–cell interactions
and extracellular matrix – on cell phenotype is indeed well
described (Santini and Rainaldi, 1999; Jacks and Weinberg, 2002;
O’Brien et al, 2002; Smalley et al, 2006; Friedrich et al, 2007).
Owing to their round compact architecture and their direct CRC
tissue origin, colospheres can be compared with colon cancer
spheres, a model previously described for colon cancer stem cell
expansion cultures (Ricci-Vitiani et al, 2007; Todaro et al, 2008;
Vermeulen et al, 2008). However, methods for obtaining
colospheres and colon cancer spheres clearly differ. Indeed,
colospheres are formed after a simple mechanical dissociation
Colon cancer cell source
Control
2x106 cells
Kidney
XenoCT320 colospheres
CT320X6 spheroids
CT320X6 single cells
Kidney capsule injection 4x104 cells
Local tumour in kidney
Injection of
XenoCT320 colospheres
Injection of
CT320X6 single cells
0/13 0/13 0/13 1/13 (8%) 3/3
0/15 0/15 0/15 0/15 3/3
0/15 2/15 (13%) 0/15 6/15 (40%) ND
Spleen Lung Liver
Lung metastasis
Figure 6 Tumorigenic and metastatic phenotype of XenoCT320 colospheres. (A) Injections of a quantity equivalent to 4 10
4 cells as colospheres,
spheroids or single-cell suspension were administered in a subrenal capsule assay in nude mice. After 14 weeks, mice were examined for local and distant
tumour development. Mice were considered negative if no tumour tissue was identified either by necropsy or by histological examination. As control,
2 10
6 cells were subcutaneously injected. (B) A well-differentiated colon adenocarcinoma was developed at the kidney site and in the lung after
XenoCT320 colosphere injection under renal capsule. A poorly differentiated colon adenocarcinoma was obtained in the kidney of one mouse after
injection of CT320X6 single cells. HES staining, magnification  5.
Table 1 Expression of CD133 and CD44 in XenoCT320 xenograft,
derived colospheres and CT320X6 and CT320 spheroids
Percentage of positive cells
CD133 CD44
XenoCT320 colospheres 64.5±21 4.4±2.3
XenoCT320 tissue
a 57.5±19 5.7±6.8
CT320X6 spheroids 13±23 2 ±2
CT320 spheroids 25±11 32.3±6.8
Data are means±s.e.m. of results from experiments carried out at least three times.
aData are given for EpCAM
+ cells sorted from XenoCT320 tissue.
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sprotocol, preserving small pieces in cultured tumour bulk, whereas
colon cancer spheres are generated after an enzymatic treatment
leading to a single-cell suspension. In addition, colon cancer
spheres require ultra-low-attachment conditions, epidermal
growth factor and fibroblast growth factor-2, plus culture for 4
weeks, whereas colospheres form in 1 day, without adding
exogenous growth factors. Furthermore, these two models also
differ by the expression profile of putative colon cancer stem cell
markers. CD133 has been reported to be a presumed colon cancer
stem cell marker (O’Brien et al, 2007; Ricci-Vitiani et al, 2007;
Todaro et al, 2008), even if this function is now challenged
(LaBarge and Bissell, 2008; Shmelkov et al, 2008), and CD44 has
been more convincingly described as an informative marker of
colon cancer stem cells in both primary tumours and xenografts
(Dalerba et al, 2007; Subramaniam et al, 2007; Du et al, 2008).
Although cells grown as undifferentiated colon cancer spheres
have been reported to be exclusively CD133
þ (Ricci-Vitiani et al,
2007), a large number of cells from colospheres expressed CD133,
but a negative population was also present. These results are
consistent with a recent study describing a variable pattern of CRC
tumours that were negative to highly positive for CD133
expression (Dalerba et al, 2007). Likewise, the rates of CD44
þ
human cells in the xenograft and the fact that CD44
þ cells were a
minority sub-population of CD133
þ cells are consistently in
agreement with previous observations by Clarke and Coll (Dalerba
et al, 2007). Therefore, colospheres closely reproduce the CD44
and CD133 expression profiles found in the parental xenograft.
In conclusion, these results show that colospheres form an
ex vivo three-dimensional model distinct from traditional spher-
oids. It is noteworthy that colospheres are formed from a random
dissociation of fragments of tumours, leading to potential
variability within resulting colospheres. In contrast, spheroids
are obtained from cell lines using the liquid overlay technique in
microwells, giving rise to a population of identical spheroids. This
heterogeneity in the colosphere population could reflect inherent
intratumoral heterogeneity. As a short-term culture model
associated with tumour aggressiveness, it might therefore be
relevant for studying metastatic processes.
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